Human papillomavirus (HPV) is the most common sexually transmitted infection in the US.
HPV vaccine is a viable source of prevention against high-risk strains that are likely to cause …

HPV vaccination coverage is suboptimal. Previous research largely focused on vaccinating
girls. This study aimed to identify factors associated with HPV vaccination among male and …

Abstract Background Despite recommendations that 11–12-year-olds receive the full three-
shot Human papillomavirus (HPV) vaccine series, national HPV immunization coverage …

Disparities in HPV vaccination coverage by metropolitan statistical area (MSA) status were
observed in the 2016 and 2017 National Immunization Survey–Teen (NIS-Teen). In 2017 …

Abstract Background In the United States (US), half of new human papillomavirus (HPV)
infections occur among young people aged 15–24 years. Despite the effectiveness of HPV …

There are substantial racial and ethnic disparities in the vaccination rate for human
papillomavirus (HPV), which helps protect against cervical cancer. Using data from the 2007 …

Human Papillomavirus (HPV) vaccination faces several barriers, including a social stigma
which carries religious and philosophical implications among parents of adolescents as well …

PURPOSE: To better understand the human papillomavirus (HPV) vaccine series initiation
among 9–17-year-old female Medicaid beneficiaries in Florida programs between June …

BACKGROUND: Little information is available on geographic disparity of human
papillomavirus (HPV) vaccination among women aged 18–26 years in the US Genital HPV …

US guidelines provided a permissive recommendation for HPV vaccine for males in 2009,
with an updated recommendation for routine vaccination in 2011. Data on vaccine uptake …